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Abstract Hyperphosphorylated tau protein is known to be a
major component of the paired helical filaments (PHFs) that
accumulate in the brain of Alzheimer’s patients. The kinase that
phosphorylated Ser-208 and Ser-210 in PHF-tau had remained
unknown. We used anti-pS208 and anti-pS210 antibodies and
Western blots to confirm that the tau-tubulin kinase (TTK)
phosphorylates tau at Ser-208 and at Ser-210. Using partial
amino acid sequences of purified bovine brain TTK, a mouse
cDNA of TTK was isolated and the sequence was determined. Its
963 bp coding region is composed of 320 amino acids and encodes
a 36 kDa protein indistinguishable in size from authentic bovine
brain TTK. Our immunoblot analysis demonstrated that TTK is
ubiquitously distributed in the rat tissues, and that it is
developmentally regulated in the rat brain. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Paired helical ¢lament (PHF)-tau accumulates in the brains
of Alzheimer’s disease (AD) patients where it is highly phos-
phorylated [1^3]. Recently 25 phosphorylation sites on PHF-
tau have been identi¢ed: 12 are proline-directed sites, the
remainder non-proline sites [4^6]. As candidates acting in
the PHF formation, various kinases such as tau protein kinase
I/glycogen synthase kinase-3L (TPKI/GSK-3L) [7^11], TPKII/
cdk5 [12], mitogen-activated protein (MAP) kinases [11,13],
and protein kinase C [14] have been reported to be involved
in the phosphorylation of the several sites listed. However, the
kinase which phosphorylates Ser-208 and Ser-210 remained
unknown. Tau-tubulin kinase (TTK) is a non-proline-directed
Ser/Thr kinase which has been puri¢ed from bovine brain [15].
TTK phosphorylates a serine that is followed by an arginine
residue, thus recognizing an SR-motif. Among the non-pro-
line-directed phosphorylation sites of PHF-tau, Ser-208 and
Ser-210 are both within the context of an SR-motif. We pre-
viously reported that TTK phosphorylates tau and the K2
fragment/tau 1 portion containing Ser-208 and Ser-210. In
order to con¢rm these phosphorylation sites by Western
blot, anti-pS208, anti-pS210 and anti-pS208, pS210 antibodies
were raised in rabbits. Furthermore, the interaction between
TTK and TPKI/GSK-3L was also examined. Here we report
the complete amino acid sequence of TTK deduced from
mouse brain cDNA and the developmental distribution of
TTK in rat tissues based on Western blot analyses.
2. Materials and methods
2.1. Materials
Wistar rats were obtained from the SCL Corp. TTK, TPKI and
TPKII were puri¢ed from bovine brain following procedures de-
scribed previously [8,15]. Recombinant GSK-3L was purchased from
Sigma. Tau and tubulin were prepared from bovine brain extracts [8],
and human recombinant Tau-441 was purchased from Panvera. The
tau peptide K2 (191^224) and the partial phosphopeptides of tau
pS202, pT205 [12], pS208 (CPGDPGTPGSPRSRTPSL), pS210
(CPGDPGTPGSRSPRTPSL), and pS208/210 (CPGDPGTPG
SPRSPRTPSL) were chemically synthesized employing the solid-phase
method and the Biosearch Model 9500 or ABI Model 431A peptide
synthesizer as described by Tsukamoto et al. [16] and Sato et al. [17].
The numbering is based on the longest human tau isoform.
2.2. Preparation of antibodies
The synthetic phospho-oligopeptides of tau (pS208, pS210, pS208/
210) and the synthetic oligopeptide of mouse TTK (TTK-C;
CSDPFDWEKSGTDGSLTTTTTSAT) were covalently cross-linked
to the carrier protein keyhole limpet hemocyanin. Rabbits were im-
munized with these conjugates and the anti-serum puri¢ed using af-
¢nity columns of Sepharose 4B coupled to each antigenic peptide as
described previously [18]. The antibodies pS199 and pT205 have been
described before by Ishiguro et al. [12].
2.3. Preparation of rat brain extracts and partial puri¢cation of the
extracts
Rat brain extracts (TS-Triton extracts) were prepared with TS bu¡-
er as described previously [19]. Protein concentrations were deter-
mined by the method of Bradford [20]. The extracts were diluted
with the same volume of 50 mM Tris^HCl, pH 7.6 containing pro-
tease inhibitors and mixed with SP Sepharose (Pharmacia Biotech)
equilibrated in the same bu¡er. The mixture was rotated overnight
at 4‡C and centrifuged at 15 000 rpm for 5 min. The beads were then
washed with 50 mM Tris^HCl, pH 8.5. The proteins bound to the
Sepharose were then extracted with the same bu¡er containing 0.5 M
NaCl (SP-extracts).
2.4. Assay of kinase activity
Phosphorylation of tau and tubulin was measured by quantifying
radioactive phosphate incorporated from [Q-32P]ATP (Amersham) at
30‡C as described previously [9]. The reaction mixture contained 200
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WM [Q-32P]ATP and 0.2^0.3 mg/ml substrate in bu¡er B (100 mM
MES-NaOH, pH 6.5, 5 mM Mg-acetate, 1 mM EGTA, 5 mM 2-mer-
captoethanol, protease inhibitors).
2.5. Western blot analysis
Sodium dodecyl sulfate (SDS)^polyacrylamide gel electrophoresis
(PAGE) and Western blot were carried out as described previously
[19]. The immunodetection was performed with the Vectastain ABC-
PO system (Vector Laboratories) or the Prot Blot AP system (Prom-
ega). The antibodies against pS208, pS210, and pS208/210 were di-
luted to 30 Wg per ml, and anti-TTK-C antibody was diluted to 15 Wg
per ml. The anti-pS199 and anti-pT205 antibody preparations were
diluted 1:1000 and AT8 (Innogenetics) 1:20. For the absorption test
of the antibodies, each antibody was incubated with the peptide (50
Wg/ml) for 1 h at 4‡C, and the supernatant after centrifugation was
analyzed. For Western blot analyses of phosphorylated tau, 1 mM
benzaidine (Sigma) was added to the reaction mixtures.
2.6. Sequencing of the TTK peptides from bovine brain
The TTK fractions (0.5 mg/5 ml) were partially puri¢ed by AF
heparin column chromatography [15] and concentrated by 5% SDS^
PAGE for 6.5 h at 18 mA in a Y-shaped gel which has been developed
by P. James of the ETH-Zentrum [21] for mass spectrometry and was
modi¢ed by us. The main bands between 40 and 28 kDa were sepa-
rated again by 3%/9% SDS^PAGE for 3 h at 10 mA. The gel was
stained with Coomassie brilliant blue (CBB, Sigma) and a single band
around 32 kDa was cut out, digested with lysylendopeptidase, AP-I
(Wako, 0.3 Wg/band), in 100 mM Tris^HCl bu¡er, pH 9.0, overnight
at 37‡C. Several peptides were obtained from the digest and puri¢ed
by reverse-phase column (C8, Inertsil, 2.1U150 mm, GL Sciences
Inc., Tokyo, Japan) chromatography. The amino acid sequences
were determined by a pulse-liquid-phase amino acid sequencer (Ap-
plied Biosystems ABI 492 cLC protein sequencer).
2.7. Ampli¢cation and isolation of TTK cDNA by PCR
The cDNA clones encoding TTK were isolated as follows. A de-
generate oligonucleotide pair corresponding to peptides B-1 and B-4
of TTK was chosen as primers (5P-GA(A/G)TT(C/T)GGIGA(A/
G)ATITA(C/T)GA(A/G)GCIATGGA-3P as the sense primer and 5P-
TAITGIC(G/T)IGCIA(A/G)ICC(A/G)AA(A/G)TCIA(A/G)CAT-3P
as the antisense primer) for PCR. PCR was performed on adult mouse
brain cDNA, and the ampli¢ed product of 419 bp was inserted into
the pPCR-Script Amp SK (+) vector (Stratagene) for DNA sequence
analysis. To obtain the full length of the cDNA sequence another
primer corresponding to the 419 bp PCR fragment was designed for
rapid ampli¢cation of cDNA ends (RACE). Primers used for the
3P region were: primer 1, 5P-TGGAGAAATTTACGATGCCTTGG-
ACATGC-3P ; primer 2, 5P-GGAGAATGTGGCGCTGAAGGTGG-
AGTCAGCTCAGC-3P, and primer 3, 5P-GCAGCCAAAGCAGG-
TTCTGAAGATGGAGG-3P. The PCR primers used for the 5P end
ampli¢cation were: primer 4, 5P-GTCTTCCCATTTCCCTGTTCC-
GATGAGC-3P ; primer 5, 5P-CTCCAAGGCAGTTGGCCAACCA-
CAAACTCCACCAAC-3P ; primer 6, 5P-GAGCCTGTGGTCATA-
TCTCTCCTTAATGG-3P. The 3P RACE and the 5P RACE were
performed using the Marathon-Ready mouse brain cDNA ampli¢ca-
tion kit (Clontech). Each PCR product was ligated into the pGEM-
Teasy vector (Promega) and subcloned for DNA sequencing.
2.8. Preparation and puri¢cation of a glutathione S-transferase
(GST)^TTK fusion protein
The plasmid pGEX-6p-2/TTK (amino acids 11^320) was con-
structed by digesting pGEX-6p-2 (Pharmacia) with SmaI and XhoI
and ligating the EcoRV/SalI fragment from pGEM-Teasy/TTK (frag-
ment D) into it. TTK was expressed in Escherichia coli strain BL21 as
a fusion protein to GST. The GST^TTK fusion protein was puri¢ed
and digested with PreScission protease (Amersham Pharmacia Bio-
tech) according to the instructions for the Bulk GST Puri¢cation
Module. The GST^TTK fusion protein was immobilized on gluta-
thione Sepharose 4B beads (Amersham Pharmacia Biotech). The
beads were divided into two tubes (tube 1 and tube 2). The beads
in tube 1 were washed with phosphate-bu¡ered saline (PBS), and the
GST^TTK fusion protein was eluted by elution bu¡er. The beads in
tube 2 were washed with cleavage bu¡er. The TTK was cleaved by
PreScission protease, and eluted by the same bu¡er. Aliquots of each
elution step were collected and processed by SDS^PAGE for product
analysis.
3. Results
3.1. Speci¢city of anti-PS208 and anti-PS210 antibodies and
Western blot analysis of tau phosphorylated by TTK
The K2 fragment/tau 1 portion of tau was being phosphor-
ylated by TTK [15]. It seemed likely that TTK phosphorylates
no other sequence besides Ser-208 and Ser-210 which are
within an SR-motif of the K2 peptide. Therefore, antibodies
Fig. 1. Phosphorylation of Ser-208 and Ser-210 of tau by TTK. (A)
Dot blot analysis of the antibodies against phosphopeptides. Each
peptide sequence of the K2 fragment of tau is indicated by arrows.
The phosphorylation sites are marked with an X on the arrows.
The peptide spots (0.2 Wg) on a nitrocellulose sheet were allowed to
react with the puri¢ed primary antibodies anti-pS208, anti-pS210,
and anti-pS208/210. The reactions were detected using the Vectas-
tain ABC-PO kit. (B) Tau (0.8 Wg) was incubated at 30‡C overnight
with (lanes 2^5 and 7^10) or without (lanes 1 and 6) TTK in a re-
action mixture (9 Wl) containing 200 WM ATP. The reaction mix-
tures were subjected to SDS^PAGE, transferred onto a nitrocellu-
lose sheet and stained with Ponceau S. (C) Immuno-analyses of a
sheet as in B were carried out with antibodies in the absence or
presence of excess phosphopeptides (50 Wg/ml). Anti-pS208 (lanes 1
and 2), anti-pS208 plus pS208 peptide (lane 3), anti-pS208 plus
pS210 peptide (lane 4), anti-pS208 plus pT205 peptide (lane 5), anti-
pS210 (lanes 6 and 7), anti-pS210 plus pS208 peptide (lane 8), anti-
pS210 plus pS210 peptide (lane 9) and anti-pS210 plus pT205 pep-
tide (lane 10). The reactions were detected using the Prot Blot AP
system. M, pre-stained size markers from BRL.
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speci¢c to pS208 or/and pS210 in tau were prepared. Fig. 1A
shows the sequence of the K2 peptide and the speci¢cities of
the anti-pS208, anti-pS210, and anti-pS208/210 antibodies to
the various regions of tau determined by dot blot tests. Anti-
pS208 bound to the pS208 peptide and less so to the pS208/
210 peptide, but not to pS202, pT205, or pS210. Anti-pS210
bound to the pS210 and the pS208/210 peptide, but not to the
pS202, pT205, or pS208 peptides. Anti-pS208/210 bound to
pS208, pS210, and the pS208/210. The results, therefore, in-
dicate that the antibodies were speci¢c to their corresponding
antigens and that they did not cross-react with other phos-
phorylation sites.
Tau was incubated with or without TTK, and the phos-
phorylated epitopes were analyzed by Western blot using
these antibodies. Fig. 1B shows the tau protein bands detected
by Ponceau S staining. The bands of tau, which have been
incubated with TTK in lanes 2^5 and 7^10, appear smeared
and slightly shifted in comparison to the bands obtained with-
out TTK (lanes 1 and 6). Fig. 1C shows the results of the
Western blot of the membrane in Fig. 1B. The tau not treated
with TTK was not stained by anti-pS208 (lane 1) or anti-
pS210 (lane 6). But the tau phosphorylated by TTK was
clearly stained by anti-pS208 (lane 2) and anti-pS210 (lane
7). The anti-pS208 antibody was completely absorbed after
incubation with the peptide pS208 (lane 3) but not after in-
cubation with peptide pS210 (lane 4) or pT205 (lane 5). Con-
versely, the anti-pS210 antibody was completely absorbed by
incubation with peptide pS210 (lane 9) but not with peptide
pS208 (lane 8) or pT205 (lane 10). The results, therefore,
prove that TTK phosphorylates tau at Ser-208 and Ser-210.
3.2. Phosphorylation of tau by TTK, TPKII, and
TPKI/GSK-3L
Tau was phosphorylated by TTK, TPKII, and TPKI/GSK-
3L from bovine brain or recombinant GSK-3L. The products
were analyzed by immunoblot using anti-pS199, anti-pT205,
and anti-AT8 (Fig. 2). In Fig. 2B, Western blot analysis
showed that the anti-pS199 antibody stained tau phosphory-
lated by TPKI/GSK-3L from bovine brain (lane 4) and re-
combinant GSK-3L (lane 5), the site of which is known to
be speci¢c for TPKI/GSK-3L [12], the antibody did not stain
tau phosphorylated by TTK (lane 2). Anti-pT205 stained tau
phosphorylated by TPKII (lane 7) and by both of the GSK-3L
proteins (lanes 8 and 9), but not tau phosphorylated by TTK
(lane 6). Anti-AT8 (speci¢c for pS203 and pT205) stained tau
phosphorylated by GSK-3L (lanes 12 and 13), but it did not
stain tau phosphorylated by TPKII (lane 11) and not by TTK
either (lane 10). These results con¢rm that TTK does not
phosphorylate tau at Ser-199, Ser-203 and Thr-205.
3.3. Phosphorylation of tau in combination with TTK and
TPKI/GSK-3L
It has been reported that the prior phosphorylation of tau
by TPKII enhances the phosphorylation by TPKI/GSK-3L
[22]. Recombinant tau was treated with or without TTK, after
which the reactivity of the recombinant GSK-3L was com-
pared (Fig. 3). It can be seen that, when tau was phosphory-
lated by TTK, the rate of Pi incorporation into tau was higher
in comparison to tau which had not been prephosphorylated.
The data suggest that TTK in£uences the TPKI/GSK-3L
phosphorylation of tau in a similar manner as does TPKII.
3.4. Amino acid sequencing of peptide fragments of TTK
The TTK protein was digested with lysylendopeptidase.
Four peptides obtained from the digest were sequenced as
B-1 [IMPSEFGEIYEAMDLLT(R)E(N)], B-2 [MEVAVLK],
B-3 [(R/S)ILESIE(A/L)(I/S)XX(V/G)(G)(F)] and B-4 [HY-
MLDFGLARQYT(N/G)TXXXV]. A search for homologous
proteins based on the sequences of these four peptides yielded
no exact matches with other protein kinases. However, the
peptides B-1, B-2, B-3, and B-4 have homologous sequences,
in this order which is based on the numbering of the amino
acid sequence deduced from cDNA of Caenorhabditis elegans,
as revealed by a homology search with the Genetyx computer
program (S.D.C.). Furthermore, the B-4 peptide contains a
sequence similar to one in the central core of the catalytic
domain, subdomain VII, of the protein kinase family [23].
By PCR using degenerated primers corresponding to the
Fig. 2. Immunoblot analyses of tau phosphorylated by TTK,
TPKII, and TPKI/GSK-3L. (A, B) Tau from bovine brain (lane 1)
was phosphorylated by TTK (lanes 2, 6, and 10), TPKII (lanes 3, 7,
and 11), TPKI/GSK-3L from bovine brain (lanes 4, 8, and 12), or
recombinant GSK-3L (lanes 5, 9, and 13). The products were ¢rst
stained with Ponceau S (A) and then analyzed by immunoblot (B)
with anti-pS199 (lanes 1^5), anti-pT205 (lanes 6^9), and anti-AT8
(lanes 10^13) antibodies.
Fig. 3. E¡ect of prior phosphorylation of tau by TTK on its phos-
phorylation by GSK-3L. First the reaction mixture containing re-
combinant tau was incubated at 30‡C overnight without (a) or with
(b) TTK. After boiling for 10 min, recombinant GSK-3L (2 U/Wl)
was added to the reaction mixtures and the phosphorylation of tau
by GSK-3L was measured as a function of time. Data points are
means þ S.D.
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Fig. 4. Structure and sequence of the mouse brain TTK cDNA. The cDNA sequence of TTK was determined as 182 bp of 5P UTR, 963 bp of
coding region (shaded box), and 350 bp of 3P UTR. The corresponding positions of peptides B-1, B-2, B-3, and B-4 of the bovine brain TTK
are indicated by underlining below the mouse amino acid sequence. The positions of primers used are indicated by arrows above the nucleotide
sequence. Fragment A is a PCR product utilizing primers derived from peptides B-1 (sense) and B-4 (antisense). Fragments B and C are the
products of 3P RACE (primer 3 as sense and AP2 as antisense) and 5P RACE (AP2 as sense and primer 4 as antisense), respectively. The prim-
er 7 as sense and the primer 8 as antisense were used in PCR to generate the PCR product represented by fragment D.
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two peptides B-1 and B-4 a DNA fragment of 419 bp was
ampli¢ed from mouse brain cDNA. The predicted amino acid
sequence encoded in the 419 bp DNA fragment (fragment A
in Fig. 4) contains regions with high homology to two of the
TTK peptides from the bovine brain (B-2 and B-3). These
results con¢rmed, therefore, that the PCR product was indeed
derived from TTK cDNA.
The 419 bp cDNA encoding a sequence of TTK was used
to probe Northern blot of total RNA from adult mouse brain.
A single, approximately 1.7 kb mRNA transcript hybridized
to the TTK probe (data not shown).
3.5. cDNA sequence of the mouse brain TTK
Further attempts were undertaken to extend the sequence
of the TTK cDNA. Primary and nested PCRs were carried
out using the adapter primers (AP1 and AP2, Clontech)
coupled with several gene speci¢c primers (primers 1^6). The
RACE-PCR ampli¢cation products were subcloned, and all
clones containing TTK fragments were sequenced. As shown
in Fig. 4, the product of the 5P RACE represented a cDNA of
798 bp (fragment C) which contained the initiation codon
ATG. The product of the 3P RACE was 1149 bp long (frag-
ment B) and contained the termination codon TGA. Both
cDNA fragments contained the DNA sequence of fragment
A, and the overlapping sequences of fragments B and C (165^
616) were identical. We, therefore, prepared by PCR fragment
D using primer 7, 5P-GCAATGAGTGGAGGAGGAGAG-
CAGCCAG-3P, as sense and the primer 8, 5P-CAGGGGT-
CAAGCGGGTGTGCACTGAGG-3P, as antisense to con-
¢rm the sequence of the coding region. Finally, the cDNA
sequence of the TTK was determined as containing 182 bp
of 5P untranslated region (UTR), 963 bp of coding region, and
350 bp of 3P UTR. The entire open reading frame encodes a
320 amino acid polypeptide with a molecular mass of 36 251
Da and an isoelectric point (pI) of 9.56. The results of a
homology search indicated that sequences homologous to
TTK are present in various kinase-like sequences as deduced
from DNA sequences obtained from mouse testis, humans,
zebra¢sh, C. elegans, and Drosophila melanogaster (Fig. 5).
A partial amino acid sequence (141^298) showed 99% identity
between brain and testis from the mouse. Another partial
amino acid sequence of the mouse brain TTK is also highly
homologous to a sequence of human-1 (86% identity, 3^108),
human-2 (100% identity, 140^196), and zebra¢sh (79%, 1^
155). The results thus suggest that TTK may be distributed
ubiquitously among various species. The nucleotide sequence
of the mouse brain TTK cDNA has been deposited in the
GenBank/EMBL/DDBJ databases (accession no. AB046593).
3.6. Preparation of a GST^TTK fusion protein and assay of
TTK activity
A GST^TTK fusion protein was prepared as described
under Section 2. The fusion protein was contained in inclusion
bodies. Nevertheless, a small amount of GST^TTK fusion
protein was puri¢ed using glutathione Sepharose 4B. The
products were then analyzed by SDS^PAGE (Fig. 6A). The
GST^TTK fusion protein as detected in lane 4 is about 62
kDa in size, while the digests of the fusion protein (TTK at
around 36 kDa and GST at 26 kDa) and the PreScission
protease (46 kDa) are seen in lane 7. As shown in Fig. 6B,
in the Western blot analysis the anti-TTK-C antibody stained
the GST^TTK fusion protein at 62 kDa in lane 3 and the
cleaved TTK at around 36 kDa in lane 4. The partially puri-
¢ed SP Sepharose 4B fractions of rat brain extracts (lanes 1
and 2), of bovine brain extract (lane 5), and of the micro-
tubule-associated protein (MTP) (lane 6) also show the
stained band corresponding to TTK around 36 kDa.
The activities of TTK on tau and tubulin were then exam-
ined for the GST^TTK fusion protein and the cleaved TTK.
Fig. 6C-1 shows that the GST^TTK fusion protein phosphor-
ylated both tau and tubulin, but the phosphorylating activity
on tau was much higher than that on tubulin. While the
cleaved TTK exhibited similar activities on tau and tubulin
(Fig. 6C-2), the ratio for both substrates was mostly the same
as was exhibited by the puri¢ed TTK from bovine brain re-
ported in a previous paper [15]. The fragment not containing
inserted TTK did not show any phosphorylating activity. The
data in Fig. 6, therefore, prove that the recombinant TTK
protein based on the mouse brain cDNA sequence has the
same TTK epitopes as the TTK in bovine brain extracts
and that it is able to phosphorylate tau and tubulin.
Fig. 5. Alignment of amino acid sequences with the mouse brain
TTK sequence. Amino acid residues 1^320 of the mouse brain TTK
in Fig. 4 were aligned with the amino acid sequences of bovine
brain TTK and various kinase-like amino acid sequences deduced
from DNA sequences. Each GenBank accession number is indicated
in parentheses: mouse testis (AI385971), human-1 (AI197837), hu-
man-2 (AA234451), zebra¢sh (z. ¢sh, AW305688), C. elegans (C.
ele., CER90), and D. melanogaster (D. mel., AC013215). Amino
acid numbers are given at the top. Amino acids identical to those in
the mouse brain TTK are indicated by dashes. X, not determined.
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3.7. Distribution of TTK in various tissues of the rat
The distribution of TTK in various tissue extracts from the
rat was studied by Western blot analysis. TTK is strongly
expressed in the brain, heart and muscle in 8 day and 10
week old rats, while its distribution is lower in the liver, thy-
mus, spleen, lung, kidney, testis, and ovary throughout both
stages of the development (data not shown). Developmental
changes in TTK expression were also examined for the rat
brain. The expression increased gradually from the embryonic
stage on and remained nearly constant after 15 days to up to
1 year. Phosphorylated tau was observed mostly between
postnatal days 1^11 using anti-pS208, but not when using
anti-pS210. The brain extracts from rats between 15 days
and 1 year of age did not show immunoreactivity with either
of the two antibodies (data not shown). The results seem to
deviate from the distribution pattern of TTK in the rat brain.
However, the distribution of phosphorylated tau in vivo must
be considered in balance with kinases and phosphatases.
4. Discussion
TPKI/GSK-3L is a major candidate among the various ki-
nases participating in the PHF formation. TPKI/GSK-3L
tends to phosphorylate serine/threonine residues in a pro-
line-rich environment, which is why the enzyme is called a
proline-directed protein kinase. Godemann et al. have con-
¢rmed that recombinant GSK-3L shows a strong attraction
for proline-directed motifs in tau in the order of Ser-396/Ser-
404, Ser-46/Thr-50, and Ser-202/Thr-205 followed by others,
while GSK-3L does not phosphorylate Ser-262 [10]. Reynolds
et al. have reported that nanoelectrospray mass spectrometry
was used to identify phosphorylation sites on recombinant tau
for three MAP kinases and GSK-3L [11]. They also identi¢ed
a new phosphorylation site, Thr-175, and one non-proline-
directed phosphorylation site, Ser-400, in addition to the
known GSK-3L phosphorylation sites on tau. TTK is a
non-proline-directed Ser/Thr kinase that has been puri¢ed
from bovine brain [15] and is, as we show here, the ¢rst kinase
known to phosphorylate Ser-208 and Ser-210 of tau, both of
which sites are PHF phosphorylation sites. Thr-212, which is
a neighboring residue close to Ser-208 in tau, has been known
to be a phosphorylation site for GSK-3L [24]. The speci¢city
of anti-pS208 has been proven by the absorption test done
with peptides pS208 and pS210. Therefore, we can be sure
that the phosphorylation site Ser-208 is a site separate from
Thr-212.
For accelerated phosphorylation of tau, TPKI/GSK-3L is
known to require prior phosphorylation by another proline-
directed protein kinase, TPKII [22], and a non-proline-di-
rected protein kinase such as AMP-dependent protein kinase,
protein kinase C, and casein kinase-II [25,26]. In our present
study we found that TTK is also a kinase that increases the
subsequent phosphorylation of tau by TPKI/GSK-3L. It
seems that the precisely timed appearance of TTK may be a
key event in the regulation of the hyperphosphorylation of tau
by TPKI/GSK-3L in vivo. Rat brain extracts during postnatal
days 1^11 were immunoreactive to anti-pS208 antibody, but
extracts after 15 days and up to 1 year were not. The immu-
noreactive period corresponds to the peak of the expression of
TPKI/GSK-3L and to the appearance of tau phosphorylated
at Ser-199 and Ser-396 by TPKI/GSK-3L in the brain extracts
[9]. Meanwhile, TTK exists throughout all developmental
stages in the rat brain, increasing for up to 15 days after birth
and then being maintained at the same level during the adult
stage. We found that phosphorylated tau as well as TPKI/
GSK-3L are distributed in the cell soma and the apical den-
drites in the neocortex and the hippocampus of adults rats, in
spite of the lower levels of phosphorylated tau, as determined
by Western blot analysis, at the adult stage [19]. The results of
the developmental distribution of TTK suggest, therefore, that
TTK might contribute to the hyperphosphorylation of tau by
TPKI/GSK-3L through the prior phosphorylation of tau in
the adult brain and also the AD brain.
We were able to obtain the complete cDNA of mouse brain
TTK and to determine the whole amino acid sequence. TTK
can be expected to be distributed widely among various spe-
cies based on our homology search results. This suggests that
TTK has an important physiological role. The preparation of
a recombinant TTK will help us to come to a clearer under-
standing of the properties of this kinase, which will contribute
to the resolution of the signi¢cance of the hyperphosphoryla-
tion of tau in PHF.
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